508 related articles for article (PubMed ID: 34767070)
1. Diverse human astrocyte and microglial transcriptional responses to Alzheimer's pathology.
Smith AM; Davey K; Tsartsalis S; Khozoie C; Fancy N; Tang SS; Liaptsi E; Weinert M; McGarry A; Muirhead RCJ; Gentleman S; Owen DR; Matthews PM
Acta Neuropathol; 2022 Jan; 143(1):75-91. PubMed ID: 34767070
[TBL] [Abstract][Full Text] [Related]
2. GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's disease.
Kamphuis W; Kooijman L; Orre M; Stassen O; Pekny M; Hol EM
Glia; 2015 Jun; 63(6):1036-56. PubMed ID: 25731615
[TBL] [Abstract][Full Text] [Related]
3. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates.
Rostami J; Mothes T; Kolahdouzan M; Eriksson O; Moslem M; Bergström J; Ingelsson M; O'Callaghan P; Healy LM; Falk A; Erlandsson A
J Neuroinflammation; 2021 Jun; 18(1):124. PubMed ID: 34082772
[TBL] [Abstract][Full Text] [Related]
5. Cyclic multiplex fluorescent immunohistochemistry and machine learning reveal distinct states of astrocytes and microglia in normal aging and Alzheimer's disease.
Muñoz-Castro C; Noori A; Magdamo CG; Li Z; Marks JD; Frosch MP; Das S; Hyman BT; Serrano-Pozo A
J Neuroinflammation; 2022 Feb; 19(1):30. PubMed ID: 35109872
[TBL] [Abstract][Full Text] [Related]
6. Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Aß pathology.
Jiwaji Z; Tiwari SS; Avilés-Reyes RX; Hooley M; Hampton D; Torvell M; Johnson DA; McQueen J; Baxter P; Sabari-Sankar K; Qiu J; He X; Fowler J; Febery J; Gregory J; Rose J; Tulloch J; Loan J; Story D; McDade K; Smith AM; Greer P; Ball M; Kind PC; Matthews PM; Smith C; Dando O; Spires-Jones TL; Johnson JA; Chandran S; Hardingham GE
Nat Commun; 2022 Jan; 13(1):135. PubMed ID: 35013236
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic profiling of microglia and astrocytes throughout aging.
Pan J; Ma N; Yu B; Zhang W; Wan J
J Neuroinflammation; 2020 Apr; 17(1):97. PubMed ID: 32238175
[TBL] [Abstract][Full Text] [Related]
8. Distinct amyloid-β and tau-associated microglia profiles in Alzheimer's disease.
Gerrits E; Brouwer N; Kooistra SM; Woodbury ME; Vermeiren Y; Lambourne M; Mulder J; Kummer M; Möller T; Biber K; Dunnen WFAD; De Deyn PP; Eggen BJL; Boddeke EWGM
Acta Neuropathol; 2021 May; 141(5):681-696. PubMed ID: 33609158
[TBL] [Abstract][Full Text] [Related]
9. BIN1 protein isoforms are differentially expressed in astrocytes, neurons, and microglia: neuronal and astrocyte BIN1 are implicated in tau pathology.
Taga M; Petyuk VA; White C; Marsh G; Ma Y; Klein HU; Connor SM; Kroshilina A; Yung CJ; Khairallah A; Olah M; Schneider J; Karhohs K; Carpenter AE; Ransohoff R; Bennett DA; Crotti A; Bradshaw EM; De Jager PL
Mol Neurodegener; 2020 Jul; 15(1):44. PubMed ID: 32727516
[TBL] [Abstract][Full Text] [Related]
10. Microglia in Alzheimer's disease.
Hansen DV; Hanson JE; Sheng M
J Cell Biol; 2018 Feb; 217(2):459-472. PubMed ID: 29196460
[TBL] [Abstract][Full Text] [Related]
11. Distinct changes in all major components of the neurovascular unit across different neuropathological stages of Alzheimer's disease.
Kirabali T; Rust R; Rigotti S; Siccoli A; Nitsch RM; Kulic L
Brain Pathol; 2020 Nov; 30(6):1056-1070. PubMed ID: 32866303
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory factors and amyloid β-induced microglial polarization promote inflammatory crosstalk with astrocytes.
Xie L; Zhang N; Zhang Q; Li C; Sandhu AF; Iii GW; Lin S; Lv P; Liu Y; Wu Q; Yu S
Aging (Albany NY); 2020 Nov; 12(22):22538-22549. PubMed ID: 33196457
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory pathology markers (activated microglia and reactive astrocytes) in early and late onset Alzheimer disease: a post mortem study.
Taipa R; Ferreira V; Brochado P; Robinson A; Reis I; Marques F; Mann DM; Melo-Pires M; Sousa N
Neuropathol Appl Neurobiol; 2018 Apr; 44(3):298-313. PubMed ID: 29044639
[TBL] [Abstract][Full Text] [Related]
14. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
[TBL] [Abstract][Full Text] [Related]
15. NDRG2 Expression Correlates with Neurofibrillary Tangles and Microglial Pathology in the Ageing Brain.
Fadul MM; Garwood CJ; Waller R; Garrett N; Heath PR; Matthews FE; Brayne C; Wharton SB; Simpson JE
Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31947996
[TBL] [Abstract][Full Text] [Related]
16. Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies.
Ji B; Maeda J; Sawada M; Ono M; Okauchi T; Inaji M; Zhang MR; Suzuki K; Ando K; Staufenbiel M; Trojanowski JQ; Lee VM; Higuchi M; Suhara T
J Neurosci; 2008 Nov; 28(47):12255-67. PubMed ID: 19020019
[TBL] [Abstract][Full Text] [Related]
17. CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia.
Lodder C; Scheyltjens I; Stancu IC; Botella Lucena P; Gutiérrez de Ravé M; Vanherle S; Vanmierlo T; Cremers N; Vanrusselt H; Brône B; Hanseeuw B; Octave JN; Bottelbergs A; Movahedi K; Dewachter I
Acta Neuropathol Commun; 2021 Jun; 9(1):108. PubMed ID: 34103079
[TBL] [Abstract][Full Text] [Related]
18. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
19. Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease.
Dandrea MR; Reiser PA; Gumula NA; Hertzog BM; Andrade-Gordon P
Biotech Histochem; 2001 Mar; 76(2):97-106. PubMed ID: 11440311
[TBL] [Abstract][Full Text] [Related]
20. Glial cells in Alzheimer's disease: From neuropathological changes to therapeutic implications.
Uddin MS; Lim LW
Ageing Res Rev; 2022 Jun; 78():101622. PubMed ID: 35427810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
